Research identifies causes and possible treatments for deadly diseases affecting children

September 11, 2017

Each year, more than half a million deaths among children under five years of age around the world are caused by diarrheal diseases—largely due to insufficient access to adequate hygiene, sanitation and clean drinking water. While there are effective preventive measures available, including vaccines, adoption is lagging in low-resource settings where the most severe cases occur.

Research conducted at the University of Maryland School of Medicine (UM SOM), has identified four pathogens are responsible for the vast majority of diarrheal illnesses - leading the way for potential new treatments.

In a recent paper published in Pediatric Clinics of North America, "The Burden and Etiology of Diarrheal Illness in Developing Countries," Karen Kotloff, MD, Professor of Pediatrics and Head of the Division of Infectious Disease and Tropical Pediatrics at UM SOM, outlined the impact and challenges of , identified the key pathogens responsible and discussed the interventions to prevent and treat this serious issue. The research was conducted in areas where there is a high burden of . This included The Gambia, Kenya, Mali, Mozambique, Bangladesh, India and Pakistan.

In 2015, diarrheal diseases caused an estimated 2.3 billion illnesses and 1.3 million deaths worldwide. Among that total, 40 percent were children under five years old and 90 percent of the deaths occurred in sub-Saharan Africa and South Asia, the research showed.

These pathogens—rotavirus, Cryptosporidium, Shigellaand enterotoxigenic Esherichia coli (ETEC)—are responsible for most diarrheal illnesses, according to Dr. Kotloff, drawing from research conducted under the Global Enteric Multicenter Study (GEMS, the largest study of childhood diarrheal diseases conducted in a developing country setting. UM SOM coordinated the GEMS study, which was funded by the Bill & Melinda Gates Foundation.

"The findings from the GEMS study show that despite the many causes of diarrhea, targeting just four pathogens could prevent the majority of serious cases," said Dr. Kotloff, who is also Associate Director of Clinical Studies at UM SOM's Center for Vaccine Research.

During the first year of a child's life, researchers found that rotavirus was the leading pathogen among the top four identified every research site. Among infants, rotavirus incidence was more than two times higher than any other pathogen.

Dr. Kotloff led the clinical and epidemiological activities in the GEMS study and UM SOM's Principal Investigator was Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor of Medicine and Associate Dean for Global Health, Vaccinology and Infectious Disease. Dr. Kotloff's latest findings also draw on a Gates Foundation-funded study underway, Vaccine Impact on Diarrhea in Africa (VIDA), which she is leading at sites in The Gambia, Kenya and Mali, to assess the causes and burden of diarrhea in children under five following the introduction of rotavirus .

Dr. Kotloff said that the five key strategies to prevent diarrheal diseases and related complications are vaccination, oral rehydration salts, administering zinc, maintaining good nutrition, and the practice of proper hygiene, particularly handwashing.

At present, there are rotavirus vaccines available internationally that are derived from live, but mild, strains, and WHO has recommended that the rotavirus vaccine for infants be included in all national immunization programs, particularly in countries where diarrheal deaths account for more than 10 percent of mortality among children under five.

"We are on the cusp of a dramatic shift in the epidemiology of pediatric diarrheal diseases since rotavirus vaccines became available," Dr. Kotloff said. "However, adoption of a rotavirus vaccine regime is lagging in low-resource settings where the most severe cases occur."

Research shows some vaccines have not been as effective in the world's poorest countries. To better understand this, investigators at UM SOM's CVD are studying the impact of vaccine introduction on the cause and incidence and cause of diarrhea in sub-Saharan Africa. Dr. Kotloff and her team are studying the effectiveness and safety of a new enhanced thermostable formulation of a called RotaTeqTM in Mali, which is intended to be more resistant to temperature fluctuations.

A diarrheal illness typically lasts several days and can leave the body dehydrated, without the water and salts necessary for survival. Extreme cases can lead to shock and death within hours. Infection from bacterial diarrheal episodes caused by pathogens such as Shigella can cause extensive damage of the intestine as a result of intense inflammation and cell death. Importantly, Dr. Kotloff noted that in addition to high rates of mortality among young children suffering from diarrheal diseases, a single episode of moderate-to-severe diarrhea can produce lasting serious health conditions, such as impaired growth and cognitive development."The GEMS study showed that children who had a serious diarrheal episode were 8.5 times more likely to die in the two months after their illness than children in their neighborhood who were the same age but did not have an episode. This highlights the importance of preventing these episodes from occurring in the first place, and paying close attention to those who do have an episode," said Dr. Kotloff.

Explore further: Rotavirus vaccines continue to reduce diarrhea hospitalizations, medical costs in US kids

More information: Karen L. Kotloff, The Burden and Etiology of Diarrheal Illness in Developing Countries, Pediatric Clinics of North America (2017). DOI: 10.1016/j.pcl.2017.03.006

Related Stories

Rotavirus vaccines continue to reduce diarrhea hospitalizations, medical costs in US kids

August 10, 2017
Following the introduction of routine childhood vaccination against rotavirus, a common cause of diarrheal illness, more than 380,000 children avoided hospitalization for diarrhea from 2008 to 2013 in the U.S., thus saving ...

New low-cost rotavirus vaccine could reduce disease burden in developing countries

March 22, 2017
A new vaccine for rotavirus was found to be 66.7% effective in preventing severe gastroenteritis caused by the virus, according to a new study from researchers at Harvard T.H. Chan School of Public Health and Epicentre, Paris. ...

Surprising findings on deadly diarrhea suggest ways to save children's lives

September 27, 2016
New research offers unprecedented insights into the causes of childhood diarrhea, the second-leading cause of death of children worldwide, and suggests that the role of pathogens such as bacteria, viruses and parasites has ...

A handful of pathogens are causing most diarrhoeal deaths and illness in children worldwide and should be targeted

May 13, 2013
New research in The Lancet reports that just four pathogens—rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin, and Shigella—are causing most cases of moderate-to-severe diarrhoea ...

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.